Recently Published Academic Studies Highlight the Importance of Monitoring Antimicrobial-Resistant Pathogens in Imported Shrimp
When President Trump signed the Consolidated Appropriations Act 2019 into law last month, the bill provided the U.S. Food and Drug Administration (FDA) with “$500,000 to test Antibiotic Resistance in Imported Seafood.” By specifically funding a testing program, Congress emphasized the importance of detecting and monitoring antimicrobial pathogens on imported seafood, including shrimp. Congress’s creation of a new testing program coincides […]
Filed Under
2018 Begins With Bangladeshi Shrimp Refused Entry for Banned Antibiotics and Indian Shrimp Refused Entry for Salmonella
Yesterday, the U.S. Food and Drug Administration (FDA) made public information regarding import refusals for the first month of 2018. In January, the FDA reported that 5 out of the 116 (4.3%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. Last month was the highest number of entry line refusals of shrimp for banned antibiotics […]